| Mrs Kimberly Frederick, CRNA | |
|
799 Lexington Ave, Mansfield, OH 44907-1906 | |
| (419) 756-5133 | |
| (419) 774-9707 |
| Full Name | Mrs Kimberly Frederick |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 36 Years |
| Location | 799 Lexington Ave, Mansfield, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427044726 | NPI | - | NPPES |
| 2290668 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | RN193878 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ohiohealth Mansfield Hospital | Mansfield, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anesthesia Associates Of Mansfield, Inc | 3870486624 | 24 |
News Archive
In 1960, scientists described the "Philadelphia chromosome" that causes chronic myeloid leukemia, and in 2001 the Food and Drug Administration approved the drug imatinib to disable the action of this cancer-causing genetic change.
Novogen Limited, an oncology drug development company, today announced a collaboration with Australian company, Genea Biocells, to accelerate testing of their super-benzopyran (SBP) drugs for degenerative diseases of the nervous system and muscles.
The Wall Street Journal on Monday examined how, although consumer-driven health plans have "motivated some workers to research what they are paying for medical care," the "employees' research often consists of going" to their managers for help.
While several COVID-19 vaccine candidates have been developed and deployed to arrest the spread of SARS-CoV-2, concern among scientists and public health authorities is mounting over the immunity escape potential of emerging viral variants. To address this problem, a group of scientists in Germany has undertaken research to identify molecular targets across viral variants to aid in the development of second and third-generation vaccines and novel therapeutics.
› Verified 7 days ago
| Entity Name | Ohiohealth Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578545273 PECOS PAC ID: 6305758426 Enrollment ID: O20031105000532 |
News Archive
In 1960, scientists described the "Philadelphia chromosome" that causes chronic myeloid leukemia, and in 2001 the Food and Drug Administration approved the drug imatinib to disable the action of this cancer-causing genetic change.
Novogen Limited, an oncology drug development company, today announced a collaboration with Australian company, Genea Biocells, to accelerate testing of their super-benzopyran (SBP) drugs for degenerative diseases of the nervous system and muscles.
The Wall Street Journal on Monday examined how, although consumer-driven health plans have "motivated some workers to research what they are paying for medical care," the "employees' research often consists of going" to their managers for help.
While several COVID-19 vaccine candidates have been developed and deployed to arrest the spread of SARS-CoV-2, concern among scientists and public health authorities is mounting over the immunity escape potential of emerging viral variants. To address this problem, a group of scientists in Germany has undertaken research to identify molecular targets across viral variants to aid in the development of second and third-generation vaccines and novel therapeutics.
› Verified 7 days ago
| Entity Name | Anesthesia Associates Of Mansfield, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407947815 PECOS PAC ID: 3870486624 Enrollment ID: O20040205000222 |
News Archive
In 1960, scientists described the "Philadelphia chromosome" that causes chronic myeloid leukemia, and in 2001 the Food and Drug Administration approved the drug imatinib to disable the action of this cancer-causing genetic change.
Novogen Limited, an oncology drug development company, today announced a collaboration with Australian company, Genea Biocells, to accelerate testing of their super-benzopyran (SBP) drugs for degenerative diseases of the nervous system and muscles.
The Wall Street Journal on Monday examined how, although consumer-driven health plans have "motivated some workers to research what they are paying for medical care," the "employees' research often consists of going" to their managers for help.
While several COVID-19 vaccine candidates have been developed and deployed to arrest the spread of SARS-CoV-2, concern among scientists and public health authorities is mounting over the immunity escape potential of emerging viral variants. To address this problem, a group of scientists in Germany has undertaken research to identify molecular targets across viral variants to aid in the development of second and third-generation vaccines and novel therapeutics.
› Verified 7 days ago
| Entity Name | Ohiohealth Regional Physician Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538552468 PECOS PAC ID: 9739496902 Enrollment ID: O20150921001772 |
News Archive
In 1960, scientists described the "Philadelphia chromosome" that causes chronic myeloid leukemia, and in 2001 the Food and Drug Administration approved the drug imatinib to disable the action of this cancer-causing genetic change.
Novogen Limited, an oncology drug development company, today announced a collaboration with Australian company, Genea Biocells, to accelerate testing of their super-benzopyran (SBP) drugs for degenerative diseases of the nervous system and muscles.
The Wall Street Journal on Monday examined how, although consumer-driven health plans have "motivated some workers to research what they are paying for medical care," the "employees' research often consists of going" to their managers for help.
While several COVID-19 vaccine candidates have been developed and deployed to arrest the spread of SARS-CoV-2, concern among scientists and public health authorities is mounting over the immunity escape potential of emerging viral variants. To address this problem, a group of scientists in Germany has undertaken research to identify molecular targets across viral variants to aid in the development of second and third-generation vaccines and novel therapeutics.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Kimberly Frederick, CRNA 130 Samaritan Ave, Ashland, OH 44805-3927 Ph: (419) 756-5133 | Mrs Kimberly Frederick, CRNA 799 Lexington Ave, Mansfield, OH 44907-1906 Ph: (419) 756-5133 |
News Archive
In 1960, scientists described the "Philadelphia chromosome" that causes chronic myeloid leukemia, and in 2001 the Food and Drug Administration approved the drug imatinib to disable the action of this cancer-causing genetic change.
Novogen Limited, an oncology drug development company, today announced a collaboration with Australian company, Genea Biocells, to accelerate testing of their super-benzopyran (SBP) drugs for degenerative diseases of the nervous system and muscles.
The Wall Street Journal on Monday examined how, although consumer-driven health plans have "motivated some workers to research what they are paying for medical care," the "employees' research often consists of going" to their managers for help.
While several COVID-19 vaccine candidates have been developed and deployed to arrest the spread of SARS-CoV-2, concern among scientists and public health authorities is mounting over the immunity escape potential of emerging viral variants. To address this problem, a group of scientists in Germany has undertaken research to identify molecular targets across viral variants to aid in the development of second and third-generation vaccines and novel therapeutics.
› Verified 7 days ago
Ms. Esther Kay Baumann, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 799 Lexington Ave, Mansfield, OH 44907 Phone: 419-756-5133 Fax: 419-774-9707 | |
Mrs. Amy Joann Secor, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 799 Lexington Ave, Mansfield, OH 44907 Phone: 419-756-5133 Fax: 419-774-9707 | |
Ms. Bethany A Biddle, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 799 Lexington Ave, Mansfield, OH 44907 Phone: 419-756-5133 | |
Michael T Platner, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 335 Glessner Ave, Mansfield, OH 44903 Phone: 419-526-8768 Fax: 419-522-4697 | |
Mrs. Heather M Strickling, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 799 Lexington Ave, Mansfield, OH 44907 Phone: 419-756-5133 Fax: 419-774-9707 | |
Garrett Luke Bennett, Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 799 Lexington Ave, Mansfield, OH 44907 Phone: 419-756-5133 Fax: 419-744-9707 |